From AVAC <[email protected]>
Subject New Episode of Px Pulse! Dive into the AMP Trials
Date May 6, 2021 6:25 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
------------------------------------------------------------
[link removed]


** New Episode of Px Pulse! Dive into the AMP Trials
------------------------------------------------------------
May 6, 2021

Dear Advocate,

Findings from two trials on antibody-mediated prevention, the AMP Trials ([link removed]) , have been generating discussion since the beginning of the year. The results are complex ([link removed]) , and the implications for HIV prevention research are unfolding. The overall efficacy finding ([link removed]) from these two Phase IIb studies was not protective. But when the broadly neutralizing antibody (bNAb) known as VRC01 was fighting strains of HIV that were highly sensitive to it, the antibody did provide partial protection. So what does that mean for the field, and what other questions have been raised by these pioneering trials?

In this episode of Px Pulse ([link removed]) , AVACers Jeanne Baron and Daisy Ouya talk to leading bNAb researcher, IAVI’s ([link removed]) Devin Sok; a veteran HIV research advocate Mark Hubbard who served on AMP ([link removed]) ’s protocol team; and a senior member of the HVTN’s ([link removed]) community engagement team, a chief explainer of the AMP trials, Gail Broder. Together, we explore why these findings point to the need for combination antibodies, the need for a better understanding of the types of HIV that are circulating in a community, the complicated implications of a key lab test and more.

For more resources on these trials and antibody research for HIV prevention generally, AVAC has you covered. See AVAC’s dedicated page on the AMP trials, stay tuned for our forthcoming publication on “understanding the AMP results” ([link removed]) , and for a broader context go to our page on antibody related research ([link removed]) with access to our updated graphics on individual bNAbs ([link removed]) and combinations ([link removed]) .

Also, be sure to check out IAVI’s special report out today, The Future of Antibody-based HIV Prevention ([link removed]) , which analyzes the results and deepens the discussion with insights from experts across the field.

For the full podcast episode, highlights and more resources, visit avac.org/px-pulse ([link removed]) . And subscribe on Apple Podcasts ([link removed]) , Spotify ([link removed]) or wherever you get your podcasts!

Best,
AVAC

============================================================
Forward This Issue Do you know someone who might be interested in receiving this newsletter?
** Forward > ([link removed])

Unsubscribe You're receiving this because you signed up for our newsletter. Not interested any longer?
** Unsubscribe > ([link removed])

Contact Us T: +1 212 796 6423
E: ** [email protected] (mailto:[email protected])
W: ** www.avac.org ([link removed])
** ([link removed])
** ([link removed])
** ([link removed])
Screenshot of the email generated on import

Message Analysis